What color bag? Three emerging practices pharmacists should know

نویسندگان

چکیده

Over recent years, more and health systems have been affected by payer care coverage policies referred to as “bagging.” These practices come about payers vertically integrated with PBMs specialty pharmacies owned those PBMs. With “bagging,” medications are filled then shipped either the patient or directly patient’s system. Medications used in bagging often intravenous drugs—such infusions for oncology rheumatoid arthritis—requiring support provider administration, although is left only professional component of reimbursement. “This something that going end up affecting a lot people inadvertently,” said Wendy Mobley-Bukstein, PharmD, BCACP, an ambulatory pharmacist associate professor pharmacy practice at Drake University Des Moines, IA. She pharmacists all settings should be familiar these terms recognize might change over time. The chain custody how filled, transported, administered differentiate various terms: ▪Brown bagging: picks prescription takes it provider’s office administration.▪White A pharmacy, predominantly discretion payer, ships provider, who holds product until arrives treatment.▪Clear internal (e.g., system–owned pharmacy) dispenses transports location drug administration. “Brown frowned upon almost exclusively,” Mobley-Bukstein. brown bagging, patients must educated on storage medication, they transport medication appointment preparation There clear safety issues while white brings its own issues. main concern continuity care. Oftentimes, steered facility other than system which currently being seen. This can due contractual agreement set forth third-party outside accept white-bagged provide administration under contracted price. “White could cause delay treatment locating will work setting appointment, awaiting delivery drug,” Brown baggingPatient acquires pharmaceuticals from their physician’s hospital administration.2. Patient obtains medicationView Large Image Figure ViewerDownload Hi-res image Download (PPT)3. Hospital/clinicView (PPT)White baggingA (hospital clinic).1. Specialty pharmacyView (PPT)2. (PPT)Clear system’s fulfills prescription, administration.1. Internal (PPT) clinic). Issues caused baggingBagging ultimately impact treated. Some common include▪Negatively quality because procurement strategies do not meet standards pharmaceutical products moving one entity another. Normally, procuring help ensure exchanges accurate, timely, follow best prior administering patient.▪Restricting providers’ ability choose options, may lead fragmented between patient, pharmacist, providers▪Limiting operational efficiencies allow choice site care, through collaborative efforts providers▪Creating additional workload providers when treatments delayed restricted Bagging include ▪Negatively

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

What every pediatrician should know about liver transplantation

Liver transplantation is the treatment of choice for children with end-stage liver disease.  Improvement in outcomes (allograft and patient survival) has led to widespread use of pediatric LT worldwide. This success is due to improvement in patient selection, transplant surgery, anesthesia/postoperative care and immunosuppression management. This review will focus on different aspects of LT whi...

متن کامل

What Clinicians Should Know

Case presentation: A 36-year-old nonsmoking, normotensive South Asian man presented to the emergency department of a community hospital with retrosternal chest pain of 60 minutes’ duration. His 12-lead ECG demonstrated 10 mm of STsegment elevation in leads V2 through V6, and he received fibrinolytic therapy within 90 minutes of symptom onset. His pain resolved, but his ST segments only partiall...

متن کامل

Biopharmaceuticals: what pharmacists need to know

A T THE beginning of the 20th century the medicines market was dominated by preparations derived from natural sources of plant, animal or mineral origin. Later these were replaced by synthetic molecules discovered in the laboratory and produced in large scale chemical plants. These drugs had an advantage over the natural products because they were consistent in their molecular structure and cou...

متن کامل

what should we know in bipps

cushing’s syndrome is a rare endocrine disease characterized by hypercortisolemia caused by excess acth secreted by the pituitary. distinguishing pituitary sources from the ectopic sources of acth is challenging because of the limited accuracy of noninvasive assays. the test that offers the highest sensitivity and specificity is bilateral inferior petrosal sinus sampling (bipss). in patients wi...

متن کامل

Biosimilars: what clinicians should know.

Biosimilar medicinal products (biosimilars) have become a reality in the European Union and will soon be available in the United States. Despite an established legal pathway for biosimilars in the European Union since 2005 and increasing and detailed regulatory guidance on data requirements for their development and licensing, many clinicians, particularly oncologists, are reluctant to consider...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Pharmacy Today

سال: 2022

ISSN: ['1042-0991', '2773-0735']

DOI: https://doi.org/10.1016/j.ptdy.2022.01.039